Nuvectis Pharma Inc (NVCT)
NASDAQ
Fin d'année 31 Décembre 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | N/A | -387.262 | -141.046 | -112.453 |
Return on Equity (%) | 200 | 233.981 | -1188.726 | -168.509 |
Return on Invested Capital (%) | 200 | -757.579 | -218.159 | -173.331 |
Operating Margin (%) | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A |
Book Value Per Share | -0.1 | 0.941 | 0.971 | 0.704 |
Earnings Per Share | -0.1 | -2.861 | -1.303 | -1.285 |
Cash Per Share | N/A | 1.274 | 1.365 | 1.104 |
Working Capital Per Share | -0.1 | 0.758 | 0.971 | 0.704 |
Operating Profit Per Share | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.1 | -2.861 | -1.303 | -1.285 |
EBITDA Per Share | -0.1 | -2.861 | -1.303 | -1.285 |
Free Cash Flow Per Share | -0.1 | -2.861 | -1.303 | -1.285 |
Fin d'année 31 Décembre 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A |
Actions en circulation | 100k | 4,51M | 14,64M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||||
Actions en circulation | 14,64M | 16,01M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 108,97M |
Ratio cours/bénéfice | -4,9 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 5,7 |
Ratio prix/valeur comptable | 8,93 |
Rendement de dividende | - |
Actions en circulation | 19,32M |
Volume moyen (1 semaine) | 75,77k |
Volume moyen (1 mois) | 112,74k |
Variation sur 52 semaines | -33,02% |
Plus haut sur 52 semaines | 12,10 |
Plus bas sur 52 semaines | 4,44 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales